Motif ID: Nkx2-3
Z-value: 0.810
Transcription factors associated with Nkx2-3:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Nkx2-3 | ENSMUSG00000044220.12 | Nkx2-3 |
Activity-expression correlation:
Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Nkx2-3 | mm10_v2_chr19_+_43612299_43612325 | 0.22 | 5.2e-02 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.1 | 78.2 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
2.9 | 17.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
1.9 | 5.7 | GO:0016095 | polyprenol catabolic process(GO:0016095) terpenoid catabolic process(GO:0016115) primary alcohol catabolic process(GO:0034310) |
1.7 | 6.7 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
1.1 | 3.4 | GO:0097274 | urea homeostasis(GO:0097274) |
1.1 | 12.9 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
1.0 | 5.1 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
1.0 | 3.0 | GO:0060023 | soft palate development(GO:0060023) |
0.9 | 2.8 | GO:0021759 | globus pallidus development(GO:0021759) |
0.7 | 2.0 | GO:0061357 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) positive regulation of Wnt protein secretion(GO:0061357) |
0.6 | 1.8 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.6 | 2.4 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.6 | 6.3 | GO:0060539 | diaphragm development(GO:0060539) |
0.5 | 2.1 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
0.5 | 5.1 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.5 | 4.0 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.5 | 1.0 | GO:0060166 | olfactory pit development(GO:0060166) |
0.5 | 1.5 | GO:0007521 | muscle cell fate determination(GO:0007521) cellular response to parathyroid hormone stimulus(GO:0071374) positive regulation of macrophage apoptotic process(GO:2000111) |
0.4 | 2.4 | GO:0003383 | apical constriction(GO:0003383) |
0.4 | 1.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) alveolar secondary septum development(GO:0061144) |
0.3 | 1.0 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.3 | 5.4 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.3 | 1.0 | GO:0021780 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.3 | 2.8 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.3 | 3.1 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.3 | 1.0 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.2 | 2.4 | GO:0061470 | interleukin-21 production(GO:0032625) T follicular helper cell differentiation(GO:0061470) interleukin-21 secretion(GO:0072619) |
0.2 | 1.0 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.2 | 1.2 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.2 | 1.6 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.2 | 1.1 | GO:0015692 | vanadium ion transport(GO:0015676) lead ion transport(GO:0015692) |
0.2 | 1.7 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.2 | 0.6 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.2 | 1.1 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.2 | 4.8 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.2 | 2.3 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.2 | 1.3 | GO:0098535 | positive regulation of centriole replication(GO:0046601) de novo centriole assembly(GO:0098535) |
0.2 | 1.1 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.2 | 5.0 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.2 | 3.6 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.2 | 0.6 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 1.2 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 1.3 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 0.4 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.1 | 3.0 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.1 | 2.0 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.1 | 1.0 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.9 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 6.2 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.1 | 0.6 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 1.9 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.1 | 0.6 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) endoplasmic reticulum tubular network assembly(GO:0071787) |
0.1 | 0.6 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.1 | 0.8 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.1 | 0.8 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.1 | 3.8 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 0.4 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 2.6 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.1 | 0.4 | GO:0002188 | translation reinitiation(GO:0002188) |
0.1 | 0.4 | GO:0019323 | pentose catabolic process(GO:0019323) |
0.1 | 0.6 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.1 | 0.8 | GO:1900194 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.1 | 0.4 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.1 | 0.8 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.1 | 1.0 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.1 | 0.3 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.1 | 3.8 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.1 | 0.9 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.3 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.1 | 0.4 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 2.8 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.1 | 0.6 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.2 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) oxidative single-stranded DNA demethylation(GO:0035552) |
0.1 | 0.6 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.1 | 0.2 | GO:0050748 | negative regulation of receptor biosynthetic process(GO:0010871) transforming growth factor-beta secretion(GO:0038044) negative regulation of lipoprotein metabolic process(GO:0050748) |
0.1 | 0.6 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.1 | 2.0 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 0.4 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.1 | 0.5 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 4.4 | GO:0007601 | visual perception(GO:0007601) |
0.0 | 0.4 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.0 | 4.4 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.5 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.0 | 1.2 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.3 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.0 | 2.1 | GO:0002066 | columnar/cuboidal epithelial cell development(GO:0002066) |
0.0 | 5.0 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.0 | 1.1 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.0 | 0.1 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.0 | 0.6 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.0 | 0.4 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.0 | 0.6 | GO:0014823 | response to activity(GO:0014823) |
0.0 | 1.3 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 2.9 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.0 | 0.7 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.0 | 0.0 | GO:0036258 | multivesicular body assembly(GO:0036258) |
0.0 | 0.3 | GO:0010650 | positive regulation of cell communication by electrical coupling(GO:0010650) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.0 | 0.4 | GO:0007094 | mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
0.0 | 1.0 | GO:0051271 | negative regulation of cell migration(GO:0030336) negative regulation of cellular component movement(GO:0051271) negative regulation of cell motility(GO:2000146) |
0.0 | 0.3 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.0 | 0.1 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.0 | 0.1 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.0 | 2.3 | GO:0000086 | G2/M transition of mitotic cell cycle(GO:0000086) |
0.0 | 0.2 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 1.7 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.0 | 1.5 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.0 | 1.9 | GO:0000910 | cytokinesis(GO:0000910) |
0.0 | 0.0 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.0 | 0.7 | GO:0071774 | response to fibroblast growth factor(GO:0071774) |
0.0 | 0.1 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 0.2 | GO:0035455 | response to interferon-alpha(GO:0035455) |
Gene overrepresentation in cellular_component category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 6.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.5 | 2.4 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.5 | 2.7 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.4 | 6.0 | GO:0005922 | connexon complex(GO:0005922) |
0.4 | 3.6 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.3 | 1.2 | GO:0060187 | cell pole(GO:0060187) |
0.3 | 2.4 | GO:0033269 | internode region of axon(GO:0033269) |
0.3 | 2.4 | GO:0005818 | aster(GO:0005818) |
0.3 | 2.0 | GO:0001940 | male pronucleus(GO:0001940) |
0.2 | 2.8 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.2 | 1.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.2 | 1.1 | GO:0070826 | paraferritin complex(GO:0070826) |
0.2 | 1.3 | GO:0098536 | deuterosome(GO:0098536) |
0.2 | 1.1 | GO:0070820 | tertiary granule(GO:0070820) |
0.2 | 1.2 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.2 | 1.6 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 2.9 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 0.6 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 1.1 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
0.1 | 1.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 4.8 | GO:0043034 | costamere(GO:0043034) |
0.1 | 2.0 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.6 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.2 | GO:0097233 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
0.1 | 0.6 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.1 | 1.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.2 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
0.1 | 1.9 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.6 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 2.0 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 1.0 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 1.4 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 1.9 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 8.7 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 1.0 | GO:0016580 | Sin3 complex(GO:0016580) |
0.0 | 0.4 | GO:0000243 | commitment complex(GO:0000243) |
0.0 | 0.1 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.0 | 2.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.8 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 0.5 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 0.6 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.0 | 1.4 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.1 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 1.2 | GO:0030425 | dendrite(GO:0030425) |
0.0 | 2.0 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.5 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 2.3 | GO:0014069 | postsynaptic density(GO:0014069) |
0.0 | 0.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.1 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.2 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.1 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.0 | 0.4 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 4.0 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.6 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 0.2 | GO:0033655 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.0 | 0.1 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
Gene overrepresentation in molecular_function category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 6.7 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.2 | 3.6 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
1.1 | 5.7 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.9 | 6.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.6 | 1.8 | GO:0004335 | galactokinase activity(GO:0004335) |
0.5 | 2.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.5 | 5.0 | GO:0048185 | activin binding(GO:0048185) |
0.5 | 1.8 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.4 | 3.6 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.4 | 3.0 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.4 | 4.5 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.3 | 2.8 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.3 | 1.6 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) phosphatidylcholine-translocating ATPase activity(GO:0090554) |
0.3 | 2.4 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.3 | 5.3 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.3 | 1.0 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.2 | 3.0 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.2 | 1.1 | GO:0015086 | cadmium ion transmembrane transporter activity(GO:0015086) lead ion transmembrane transporter activity(GO:0015094) vanadium ion transmembrane transporter activity(GO:0015100) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
0.2 | 82.9 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.2 | 0.8 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) gap junction channel activity involved in cell communication by electrical coupling(GO:1903763) |
0.2 | 0.6 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 1.0 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.4 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 1.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 1.3 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.1 | 23.7 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.1 | 1.2 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.1 | 4.4 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 2.8 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 0.8 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 0.9 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.1 | 0.6 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 4.4 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.8 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 2.9 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.3 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.1 | 4.9 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.1 | 0.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 0.4 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 0.5 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 3.0 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 0.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 1.0 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 1.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.5 | GO:0032564 | dATP binding(GO:0032564) |
0.1 | 1.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 2.4 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.4 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.0 | 0.2 | GO:0043734 | DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.0 | 2.3 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.0 | 0.6 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 5.1 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
0.0 | 0.2 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) neuregulin binding(GO:0038132) |
0.0 | 4.7 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.3 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.0 | 1.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 5.3 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.3 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.0 | 0.4 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.4 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 1.5 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.2 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.4 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) |
0.0 | 1.0 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.4 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.3 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.2 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.1 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 1.0 | GO:0001047 | core promoter binding(GO:0001047) |
0.0 | 0.2 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.3 | GO:0017022 | myosin binding(GO:0017022) |
Gene overrepresentation in C2:CP category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 78.8 | PID_P38_MK2_PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 7.8 | SA_PTEN_PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 6.0 | ST_WNT_BETA_CATENIN_PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 2.0 | SA_REG_CASCADE_OF_CYCLIN_EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 5.0 | PID_BMP_PATHWAY | BMP receptor signaling |
0.1 | 3.9 | PID_HNF3B_PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 2.4 | PID_AURORA_A_PATHWAY | Aurora A signaling |
0.1 | 2.2 | NABA_BASEMENT_MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 1.7 | PID_HDAC_CLASSIII_PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 3.6 | PID_LKB1_PATHWAY | LKB1 signaling events |
0.1 | 2.4 | SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 2.1 | PID_AURORA_B_PATHWAY | Aurora B signaling |
0.0 | 1.5 | PID_MAPK_TRK_PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.9 | PID_PDGFRA_PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 1.0 | PID_P38_MKK3_6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.6 | PID_CIRCADIAN_PATHWAY | Circadian rhythm pathway |
0.0 | 1.1 | PID_HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.8 | PID_FRA_PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.6 | PID_ARF6_DOWNSTREAM_PATHWAY | Arf6 downstream pathway |
0.0 | 3.6 | NABA_ECM_REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.8 | PID_EPHB_FWD_PATHWAY | EPHB forward signaling |
0.0 | 0.6 | PID_AP1_PATHWAY | AP-1 transcription factor network |
0.0 | 1.2 | PID_AR_PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.3 | PID_NEPHRIN_NEPH1_PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.4 | PID_LIS1_PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.2 | PID_NCADHERIN_PATHWAY | N-cadherin signaling events |
Gene overrepresentation in C2:CP:REACTOME category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 6.0 | REACTOME_GAP_JUNCTION_ASSEMBLY | Genes involved in Gap junction assembly |
0.3 | 3.0 | REACTOME_P2Y_RECEPTORS | Genes involved in P2Y receptors |
0.2 | 1.3 | REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.2 | 6.1 | REACTOME_HS_GAG_BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 2.5 | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 2.0 | REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 2.4 | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 1.3 | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 1.1 | REACTOME_PROTEOLYTIC_CLEAVAGE_OF_SNARE_COMPLEX_PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 1.0 | REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 2.4 | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 2.0 | REACTOME_ERK_MAPK_TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 0.9 | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 0.5 | REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 0.6 | REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.0 | 3.6 | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.5 | REACTOME_REGULATION_OF_RHEB_GTPASE_ACTIVITY_BY_AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.6 | REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 1.9 | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 1.7 | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.6 | REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 0.5 | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.6 | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.1 | REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.4 | REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.0 | 1.3 | REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 1.4 | REACTOME_MITOTIC_PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.6 | REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C | Genes involved in Autodegradation of Cdh1 by Cdh1:APC/C |
0.0 | 0.2 | REACTOME_PECAM1_INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.4 | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.3 | REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |